Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C548S421000, C548S466000
Reexamination Certificate
active
07144912
ABSTRACT:
The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for causing immunosuppression. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing an autoimmune disease.
REFERENCES:
patent: 2673855 (1954-03-01), Nager
patent: 5691334 (1997-11-01), Doria et al.
patent: 5847127 (1998-12-01), D'Alessio et al.
patent: 6369096 (2002-04-01), D'Alessio et al.
patent: 6407244 (2002-06-01), Murthy et al.
patent: 6602879 (2003-08-01), Murthy et al.
patent: 6638968 (2003-10-01), Kim et al.
patent: 2003/0119894 (2003-06-01), Murthy et al.
patent: 2155096 (1995-06-01), None
patent: 55162758 (1986-08-01), None
patent: 61-280429 (1988-12-01), None
patent: 02250828 (1990-10-01), None
patent: 2250828 (1990-10-01), None
patent: 09-030967 (1997-02-01), None
patent: 10-120562 (1998-05-01), None
patent: 10-120563 (1998-05-01), None
patent: 11-209283 (1999-08-01), None
patent: WO-98/11894 (1998-03-01), None
patent: WO-98/40380 (1998-09-01), None
patent: WO-99/15690 (1999-04-01), None
patent: WO-99/29309 (1999-08-01), None
patent: WO-99/40069 (1999-08-01), None
Boger, et al. “Total Synthesis of Prodigiosin, prodigiosene, and Desmethoxyprodigiosin,” J. Org. Chem., vol. 53, pp. 1405-1415, 1988.
Nakai, et al. Transplantation Proceedings, vol. 32(6), pp. 1324-1325 (2000).
Gerber, et al., Journal of Organic Chemistry, vol. 37(6), 1176-1179, (1979).
Furstner, et al. Journal of Organic Chemistry, vol. 64, pp. 8275-8280, (1999).
Yamamoto, et al. Hepatology, vol. 30(4), pp. 894-902 (1999).
Boger and Patel, 1988, “Total Synthesis of Prodigiosin, Prodigiosene, and Desmethosyprodigiosin: Diels-Alder Reactions of Heterocyclic Azadienes and Development of an Effective Palladium(III)-Promoted 2,2′-Bipyrrole Coupling Procedure”, J. Org. Chem. 53(7):1405-1415.
Abel, et al., 2000, “Aggregate formation from 3-alkylindoles; amphiphilic models for interfacial helix anchoring groups,” Chem. Comm. 433-434.
Anderson, et al., 1985, “The Synthesis of 3-Substituted Pyrroles from Pyrrole,” Synthesis, 353-364.
Applebaum, 1992, “The role of the immune system in the pathogenesis of cancer”, Semin. Oncol. Nurs. 8(1):51-62.
Azuma, et al., 2000, “Induction of apoptosis of activated murine splenic T cells by cycloprodiglosin hydrochloride, a novel immunosuppressant”, Immunopharmacology 46(1):29-37.
Birkeland et al., 2000, “Cancer risk in patients on dialysis and after renal transplantation”, Lancet 355(8218):1886-7.
Blake, et al. 1990, “A short synthesis of prodiglosin analogues,” J. Chem. Soc., Chem. Comm. 734-736.
Boger and Patel, 1987, “Total Synthesis of Prodigiosin”, Tetrahedron Lett. 28:2499-2502.
Botti et al., 1998, “Immunosupressive factors: role in cancer development and progession”, Int'l. J. Biol. Mark. 13(2):51-69.
Castro, A. et al., “Antimicrobial Properties of Pyrrole Derivatives,” J. Med. Chem., vol. 10(1), pp. 29-32 (Jan. 1967).
Cortesina et al., 1993, “Immunomodulation therapy for squamous cell carcinoma of the head and neck”, Head Neck. 15(3):266-70.
D'Alessio and Rossi, 1996, “Short Synthesis of Undecyprodigiosine. A New Route to 2,2′-Bipyrrolyl-Pyrromethene Systems”, Synlett 6:513-514.
D'Alessio, R., et al., “Synthesis and Immunosuppressive Activity of Noval Prodigiosin Derivatives,” J. Med. Chem., vol. 43, pp. 2557-2565 (2000).
Duc, et al. 1992, “Methyl (E)-4-Chloro-3-methoxy-2-butenoate: An Extremely Versatile Four Carbon Building Block,” Synthesis, 391-394.
Furstner et al., 1998, “Platinum- and Acid-Catalyzed Enyne Metathesis Reactions: Mechanistic Studies and Applications to the Syntheses ofStreptorubinB and Metacycloprodigiosin”, J. Am. Chem. Soc. 120:8305-8314.
Furstner, A., et al., “Total Synthesis and Structural Refinement of the Cyclic Tripyrrole Pigment Nonylprodigiosin,” J. Org. Chem., vol. 64(22) pp. 8275-8280 (1999).
Furstner, et al., 1998, “Total Synthesis of Roseophilin,” J. Am. Chem. Soc. 120:2817-2825.
Gerber and Lechevalier, 1976, “Prodiginine (Prodigiosin-Like) Pigments fromStreptomycesand Other Aerobic Actinomycetas”, Can. J. Microbiol. 22:658-667.
Gerber and Stahly, 1975, “Prodiginine (Prodigiosin-Like) Pigments fromStreptoverticillium rubrireticuli, an Organism That Causes Pink Staining of Polyvinyl Chloride”, Appl. Microbiol. 30:807-810.
Gerber et al., “Biosynthesis of Prodiginines, .sup.13 C Resonance Assignments and Enrichment Patterns in Nonyl- Cyclononyl-, Methylcyclodecyl-, and Butylcycloheptylprodiginine Produced by Actinomycete Cultures Supplemented with .sup.13 C-Labeled Acetate and .sup.15 N-Labeled Nitrate”, Can. J. Chem. 56:1155-1163.
Gerber, 1973, “Minor Prodiginine Pigments from Actionomadura madurae and Actinomadura pelletien”, J. Hetarocycl. Chem. 10:925-929.
Gerber, 1975, “A New Prodiginine (Prodigiosin-Like) Pigment fromStreptomyces. Antimalarial Activity of Several Prodiginines”, J. Antibiotics 28:194-199.
Gerber, 1975, “Prodigiosin-Like Pigments”, CRC Crit. Rev. Microbiol. 3:469-485.
Goping et al., “Regulated Targeting of BAX to Mitochondria”, J. Cell Biol. 143:207-215.
Guseva and Balshin, 1992 “Comparative Efficacy of Prodigiosan and Proper-Myl Action on Neutrophil Phagocytosis in Acute Myeloblastic Leukemia”, Antibiot. Khimioter. 37:44-46 (in Russian w/English abstract).
Guseva and Tishenko, 1989, “The Effect of Prodigiosan on Antibody-Dependent Cytotoxicity of Neutrophils in Chronic Myeloid Leukemia”, Vopr. Onkol. 35:30-34 (in Russian w/English abstract).
Hearn, W., et al., “Prodigiosene [5-(2-Pyrryl)-2,2′-dipyrrylmethene] and Some Substituted Prodigiosenes,” J. Org. Chem., vol. 35(1) pp. 142-146 (Jan. 1970).
Hojo et al., 1999, “Cyclosporina Induces Cancer Progression by a Cell-Autonomous Mechanism”, Nature 397:530-534.
http://dbs.p.kanazawa-u.ac.ip/-seika/home-e.html Faculty of Pharmaceutical Science at the University of Kanazawa (2000).
Korsmeyer, 1992, “Bcl-2: A Repressor of Lymphocyte Death”, Immunol. Today 13:285-288.
Laatsch and Thomson, 1983, “A Revised Structure for Cycloprodigiosin”, Tetrahedron Lett. 24:2701-2704.
Laatsch et al., 1991, “Butyl-meta-Cycloheptylprodiginine—a Revision of the Structure of the Former Ortho-Isomer”, J. Antibiot. 44:187-191.
Marshall et al., 1999, “Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Appoptosis and Associates with Bax and Bak”, J. Virol. 73:5181-5185.
Matsunaga et al., 1986, “Bioactive Marine Metabolites. VIII. Isolation of an Antimicrobial Blue Pigment from the Bryozoan Bugula dentata”, Experientia 42:84.
Melvin, M. et al., “DNA Binding by 4-Methoxypyrrolic Natural Products,” J. Org. Chem., vol. 64(18), pp. 6861-6869 (1999).
Mitsuya et al., 1991, “Targeted Therapy of Human Immunodeficiency Virus-Related Disease”, FASEB J. 5:2369-2381.
Molecular Biology of the Cell (2ed. 1989) edited et al., Garland Publishing, Inc.:New York, pp. 727-761 and 1203-1215.
Montaner et al., 2000, “Prodigiosin from the supernata
Attardo Giorgio
Johnson Roy A.
Gemin X Biotechnologies Inc.
Grazier Nyeemah
Saeed Kamal A.
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Pyrrole-type compounds, compositions, and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrole-type compounds, compositions, and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole-type compounds, compositions, and methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720355